Bahrain Unified Drug Prices Report

1
Bahrain Unified Drug Prices Report
One-Stop Shop for Business Information
2
Summary
Report Overview This product offers a detailed
outlook on Bahrain's pharmaceutical market. The
report provides the latest 2014 CIF price for
over 22,000 products that are categorized by
pharmaceutical form, route of administration,
pack size, strength, registration status and
current local agent. The report also provides a
qualitative analysis of trends in the Bahraini
pharmaceutical market and its relation to both
GCC and global markets. Report Fast
Facts Release Dates Released in March October
annually Geographical Areas Covered Bahrain
3
Analysis Scope latest price comparison across
23,000 unique products, 110 categories by
product's generic name, trade name, manufacturer,
dosage form, pack size and concentration Report
Content Tabular graphical analysis along with
all report sources Report Sources Several
hundred pharmaceutical distributors, agents,
physicians, Bahrain's MOH health ministers'
council for GCC states, The National Health
Regulatory Authority (NHRA) Report Size 120
pages Report Format Secure PDF access to
downloadable source database (optional) Cost
1,900 - 5,010 (based on Drug Groups selected )
4
Tables Figures 2014 Bahrain CIF price
comparisons (per pack) for over 23,000 unique
products in over 110 categories 2014 Bahrain
CIF price comparisons (per pill) for over 23,000
unique products in over 110 categories Reasons
to Buy Facilitate decision making based on the
new price regulation and the level of competition
across drug categories Position yourself to
utilize potential growth in products, with high
profit margins and scarce supply Update sales
and turnover forecasts given the new government
regulation on prices
5
Drug Categories ReportedSystematic
Antibiotics Antibiotics Antifungal
Antibacterial Antiprotozoal agents Mineral
supplements Vitamins Dehydration
supplements Antacids Antispasmoics
Alimentary tract metabolism
6
Anti-depressants Anti-Parkinson Agent
Anti-psychotic CNS-Schizophrenia CNS-
anesthetics Dermatological Anti-viral
Anti-Acne Dermatological Antibiotics
Chemotherapeutics Rematological-Antifungal
Dermatological Antipuritics
7
Beta Adrenoceptors / Blocking agents
Bronchodilators and Asthma Drugs Antiplatelet
drugs CVS- antihypertensives CVS-cardiac
therapy Vasoprotectives Immuno suppressive
drugs Antineoplastics Cytostatics Endocrine
therapy Immunostimulating agents Blood and
Blood forming organs
8
Related Reports

• The 2013-2018 Outlook for Intravenous (IV) Iron
  Drugs in Asia the Middle East
• The 2013-2018 Outlook for Intravenous (IV) Iron
  Drugs in the United States
• The 2013-2018 Outlook for Intravenous (IV) Iron
  Drugs in North America the Caribbean
• The 2013-2018 Outlook for Intravenous (IV) Iron
  Drugs in Africa
• The 2013-2018 Outlook for Intravenous (IV) Iron
  Drugs in Europe

9
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and benchmarks.

10
For More Information You Can Visit

• https//www.bharatbook.com/business-services-marke
  t-research-reports-482786/bahrain-unified-drug-pri
  ces-report.html

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email
info_at_bharatbook.com